Innovative Hematology
Innovative Hematology reported $35.9 million in revenue and $20.0 million in expenses for calendar year 2024. Of every $100 it spent, $87.18 went to program services, $12.62 to management and general costs and $0.20 to fundraising. Its largest source of revenue was investment income: 29.2% of the total. The highest compensation it reported for one person was $1,095,913 (PRESIDENT/CEO/MED DIR). 14 people received more than $100,000 in reportable compensation. Source: Form 990, 2024.
Where $100 of spending went
Calendar year 2024 · Form 990, Part IX, line 25 · total expenses $20MFor context, the median across 5,634 covered health care charities: $86.19 programs, $13.81 management, $0.00 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
Calendar year 2024 · Form 990, Part VIII · total revenue $36MThe 990 scorecard · same measures for every charity, no grades
| Measure | 2024 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 87.2% | 85.6% |
| Management & general Part IX 25(C) ÷ 25(A) | 12.6% | 13.7% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.2% | 0.0% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | Not reported | $0.00 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 0.7% | 1.3% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.1% | 0.1% |
| Program service revenue share Part VIII 2g ÷ 12 | 3.3% | 93.7% |
| Highest reported compensation Part VII-A, columns D–F | $1,095,913 | $975,831 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 5.47% | 1.34% |
| People paid over $100,000 Part VII, line 2 | 14 | 27 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 99.6 | 6.6 |
| Independent voting board members Part VI 1a–1b | 7 of 11 | 88.9% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
2024 · Form 990, Part III · the three largest programs by expenseInnovative Hematology is a non-profit, tax-exempt organization with the mission of providing the highest quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders, and to their families. Innovative Hematology was established in 2024 and serves both adult and pediatric patients throughout the state of indiana. Innovative Hematology utilizes a multidisciplinary approach to treating patients with complex medical problems and participates in clinical research and education of medical students, residents, fellows, patients, families, and…
Highest reported compensation
2024 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| PRESIDENT/CEO/MED DIR Director/trustee, officer, 40.00 hrs/week | $811,705 | $211,406 | $72,802 | $1,095,913 |
| HEMATOLOGIST Highest compensated employee, 32.00 hrs/week | $406,356 | $167,605 | $90,418 | $664,379 |
| HEMATOLOGIST Highest compensated employee, 32.00 hrs/week | $414,940 | $169,365 | $78,343 | $662,648 |
| HEMATOLOGIST Highest compensated employee, 32.00 hrs/week | $402,956 | $165,050 | $91,525 | $659,531 |
| HEMATOLOGIST Highest compensated employee, 31.00 hrs/week | $399,956 | $174,880 | $68,990 | $643,826 |
| HEMATOLOGIST Highest compensated employee, 30.00 hrs/week | $344,956 | $171,795 | $82,266 | $599,017 |
| CHIEF OPERATIONS OFFICER Officer, 27.00 hrs/week | $279,957 | $180,878 | $89,707 | $550,542 |
| DIRECTOR/MED DIR Director/trustee, officer, 20.00 hrs/week | $384,803 | $92,143 | $47,730 | $524,676 |
14 people received more than $100,000 in reportable compensation from Innovative Hematology (Part VII, line 2). Compensation of current officers, directors and key employees totaled $3.2M (Part IX, line 5).
1 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
2024 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b11 · 7 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2Yes
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4Yes
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 50
Largest outside contractors
2024 · Form 990, Part VII, Section B · businesses only| CHOICE SOLUTIONS LLC Is consultants | $129,235 |
Individuals listed as contractors are left out. 1 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from Innovative Hematology's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Innovative Hematology, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 Innovative Hematology spent in 2024, $87.18 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Brownsville Community Development CorpBrooklyn, NY · revenue $36M · programs 86.6% · 2024
- Corry Memorial Hospital AssociationCorry, PA · revenue $36M · programs 86.6% · FY2025
- Sisters of St Mary of Oregon Maryville CorporationBeaverton, OR · revenue $36M · programs 89.8% · FY2025
- Lutheran Homes of MichiganSaginaw, MI · revenue $36M · programs 76.2% · 2024
- Phoebe Berks Health CARE CenterWernersville, PA · revenue $36M · programs 86.1% · FY2025
Questions people ask
How much of Innovative Hematology's spending goes to programs?
In calendar year 2024, Innovative Hematology reported that 87.2% of its $20.0 million in expenses went to program services, 12.6% to management and general and 0.2% to fundraising (Form 990, Part IX).
How much does Innovative Hematology pay its top executive?
The largest total compensation Innovative Hematology reported for one person in calendar year 2024 was $1,095,913, for the role of PRESIDENT/CEO/MED DIR (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does Innovative Hematology get its money?
Of $35.9 million in revenue in calendar year 2024, 0.7% came from contributions and grants (including 0.1% from government grants) and 3.3% from program service revenue (Form 990, Part VIII).
Is Innovative Hematology a registered charity?
The IRS lists EIN 92-3243582 as a 501(c)(3) organization (hospital or medical research organization), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- 2024: Form 990 for calendar year 2024, object 202533199349300328 · read the filing · XML
All filings for EIN 92-3243582: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.